Sultova, Elena
Westphalen, C. Benedikt
Jung, Andreas
Kumbrink, Joerg
Kirchner, Thomas
Mayr, Doris
Rudelius, Martina
Ormanns, Steffen
Heinemann, Volker
Metzeler, Klaus H.
Greif, Philipp A.
Burges, Alexander
Trillsch, Fabian
Mahner, Sven
Harbeck, Nadia
Wuerstlein, Rachel http://orcid.org/0000-0001-7268-0840
Funding for this research was provided by:
Universitätsklinik München
Article History
Received: 14 August 2020
Accepted: 4 November 2020
First Online: 4 December 2020
Compliance with ethical standards
:
: CBW received personal and speakers’ fees, reimbursement for travel and accommodation and honoraria for participance in advisory boards from Bayer, Celgene, Ipsen, Rafael Pharmaceuticals, RedHill, Roche, Servier, Shire/Baxalta and Taiho and grant support by Roche. AJ received honoraria and reimbursement for travel and accommodation for participance in advisory boards and from speaker's bureau from Amgen, AstraZeneca, Biocartis, Bristo-Myers Squibb (BMS), Boehringer Ingelheim, Chinese Society for Pathology, German Society for Pathology, European Association for Cancer Research (EACR), International Association for Pathology (IAP), Merck-Serono, Merck-Sharp Dohme (MSD), Quality Initiative in Pathology (QuIP), Roche Pharma, Takeda; JK received honoraria and reimbursement for travel and accommodation for participance in advisory boards and from speaker's bureau from AstraZeneca, Novartis, Quality Initiative in Pathology (QuIP), Roche Pharma. TK received honoraria and reimbursement for travel and accommodation for participance in advisory boards from Amgen, AstraZeneca, Merck KGaA, MSD, Novartis, Pfizer, Roche; and from speaker's bureau from Merck and Astra Zeneca; from Merck and Roche research funding as well. KHM received honoraria from Celgene, Pfizer, Astellas, Daiichi Sankyo and Otsuka Pharma. AB received honoraria and reimbursement for travel and accommodation for participance in advisory boards from AstraZeneka, Roche and Tesaro. FT received research support, reimbursement for travel and accommodation for participance in advisory boards and from speaker's bureau from AstraZeneca, Clovis, Medac, PharmaMar, Roche, Tesaro/GSK. SM received research support, advisory board, honoraria and travel expenses from AbbVie, AstraZeneca, Clovis, Eisai, GlaxoSmithKline, Medac, MSD, Novartis, Olympus, PharmaMar, Pfizer, Roche, Sensor Kinesis, Teva, Tesaro. NH received honoraria for lectures and/or consulting from Agendia, Amgen, Astra Zeneca, BMS, Celgene, Daiichi-Sankyo, Genomic Health, Lilly, MSD, Novartis, Odonate, Pierre Fabre, Pfizer, Roche, Sandoz/Hexal, Seattle Genetics. RW received honoraria for lectures and/or consulting from Agendia, Amgen, Aristo, Astra Zeneca, Celgene, Clinsol, Daiichi-Sankyo, Eisai, Genomic Health, Glaxo Smith Kline, Hexal, Lilly, Medstrom Medical, MSD, Mundipharma, Nanostring, Novartis, Odonate, Paxman, Palleos, Pfizer, Pierre Fabre, PumaBiotechnolgogy, Riemser, Roche, Sandoz/Hexal, Seattle Genetics, Tesaro Bio, Teva.
: The study received approval of the local ethics committee (study number: 284–10) and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.